Recursion Secondary Offering includes Funds for dozens of clinical trials as well as Acquisitions
prospectus of secondary offering resolves two key areas in 4-6 quarters with funds coveing potentially dozensof clinical trials as well as acquisitions.
In May, Recursion also stated that they have future partnerships as well as current partners whose trials include non-dilutive funding as these clical trials progress.
Increased my stake by 15% ![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Veteran US Army 🇺🇸
Crypto: BTC SOL
Stocks: RXRX CYBR HTHT FSR
Real Estate 🏡
Artificial Intelligence ⭐️
49Followers
132Following
213Visitors
Follow